ABTABBOTT LABORATORIES

NYSE abbott.com


$ 102.04 $ 1.96 (1.96 %)    

Friday, 19-Jul-2024 15:59:54 EDT
QQQ $ 475.02 $ -4.25 (-0.89 %)
DIA $ 402.92 $ -3.77 (-0.93 %)
SPY $ 548.99 $ -3.67 (-0.66 %)
TLT $ 92.97 $ -0.55 (-0.59 %)
GLD $ 221.79 $ -4.05 (-1.79 %)
$ 102.03
$ 100.68
$ 0.00 x 0
$ 0.00 x 0
$ 100.13 - $ 102.38
$ 88.33 - $ 120.40
11,963,581
na
178.52B
$ 0.75
$ 31.71
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-16-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-17-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-19-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-29-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-22-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-06-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 abbott-labs-makes-marketing-push-for-new-glucose-monitors-targets-health-conscious-consumers

Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizin...

 dow-plunges-over-500-points-following-unexpected-surge-in-us-jobless-claims

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the "Neutral&...

 why-are-abbott-laboratories-shares-trading-lower

Shares of Abbott Laboratories (NYSE: ABT) are trading lower on Thursday following the company's announcement of its second-...

 vix-stages-double-digit-spike-as-risk-off-takes-over-chipmakers-fail-to-rebound-weight-loss-giants-eli-lilly-novo-tumble-whats-driving-markets-thursday

It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), ofte...

 abbott-laboratories-q2-earnings-revenue-and-profit-beat-estimates-nudges-up-annual-profit-guidance-on-strong-medical-devices-growth

Abbott Laboratories reported Q2 sales of $10.38 billion, driven by 10.2% growth in Medical Devices, beating EPS estimates with ...

 wall-street-gearing-up-for-tech-led-rebound-ahead-of-netflix-earnings-economist-expects-soft-landing-but-says-brace-for-bigger-fed-rate-cuts-if-this-happens

Beaten-down stocks could make a comeback on Thursday, with Taiwan Semiconductor Manufacturing Company Ltd.’s (NYSE:TSM) strong ...

 nasdaq-sees-worst-session-since-2022-as-chip-stocks-tumble-after-trumps-taiwan-remarks-and-bidens-potential-restrictions

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Neutral&...

 netflix-goldman-sachs-jj-asml-lead-q2-reports-this-week-as-analysts-see-earnings-growth-accelerating-to-fastest-in-over-2-years

Following a lackluster big bank earnings, market participants now turn their attention to the unfolding week, expecting the tre...

 similac-baby-formula-maker-abbott-and-reckitt-face-hundreds-of-baby-formula-lawsuits

Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial a...

 evercore-isi-group-maintains-outperform-on-abbott-laboratories-lowers-price-target-to-120

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price targe...

 fda-says-abbott-medical-issues-correction-for-heartmate-lvas-system-monitor-due-to-screen-issues-that-could-cause-unintentional-pump-stop

- Reuters